about
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Read More
16.26
-0.25
(-1.51%)
138.6K
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Amarin Corp (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..